Events

USPTO’s next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting

The USPTO announced its next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting will be held on September 14th (Monday) from 9:00 am – 5:00 pm.  It will be jointly hosted by Technology Centers 1600 (Biotechnology and Organic Chemistry) and 1700 (Chemical and Materials Engineering).  The BCP Meeting will be…
Continue Reading >

Medical Device Group Expanding

MH2 is pleased to announce the expansion of its Medical Device group with the addition of Urmi Chattopadhyay as a Patent Agent.  Urmi brings over fourteen years of medical device experience to the Firm as a former engineer, patent examiner, industry consultant, and patent agent in this field.  Urmi joins…
Continue Reading >

USPTO Issues Interim Guidance Regarding Patent Subject Matter Eligibility

On 16 December 2014, the USPTO issued its much anticipated Interim Guidance Regarding Patent Subject Matter Eligibility and provided new explanatory training examples relating to nature-based products.  The December 16 guidance supersedes the USPTO’s 4 March 2014 guidance and issued in view of the Supreme Court decisions in Myriad and…
Continue Reading >

Timothy Hsieh and Bryan Wilson to speak at STC.UNM’s Fall Seminar

Timothy Hsieh and Bryan Wilson will present “A Start-up’s Guide to Avoiding Intellectual Property Pitfalls” at STC.UNM’s Fall Seminar on Thursday, November 6, 2014 at 8:00 AM. Additional information can be found here.

MH2 Expands Its Biotech and Chemical Practice

MH2 Law proudly announces that Cynthia L. Martin has joined the firm. Cynthia, formerly in-house at Eli Lilly and Company, specializes in patent drafting, prosecution, and opinion work for chemical, biotechnology/pharmaceutical, and nanotechnology related inventions.

Search